Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vinorelbine in Mesothelioma (VIM)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2014 by Velindre NHS Trust.
Recruitment status was:  Not yet recruiting
Sponsor:
Collaborators:
Wales Cancer Trials Unit
Pierre Fabre Laboratories
Information provided by (Responsible Party):
Lisette Nixon, Velindre NHS Trust
ClinicalTrials.gov Identifier:
NCT02139904
First received: May 9, 2014
Last updated: May 13, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)